0.01
1-alkyl-2-acetyl-sn-glycerol cholinephosphotransferase
10-cell decrease
10-eo-cfu increase
15-ml/min
2-vessel cad
2-way anova
229 ml
24-hour brachial systolic pressure
3-vessel cad
8-fluo-camp binding
90-day mortality
95% confidence interval
aac
aan stage heart failure
aanemia in patients with heart disease
aanrial fibrillation
aas
abd classification
abdominal aortic constriction
abnormal body composition
abnormal ca(2+) handling
abnormal cardiac t2
abnormal hr variability
abnormal liver texture changes
abnormal scn5a mrna splicing
absolute risk
absorption function
acc
acetyl-lysine reader proteins
acetylcholinesterase inhibition
acetylcholinesterase inhibitor pyridostigmine
acf
acp
acquired heart failure
acr
acs
acs problems
acs procedures
actin cytoskeleton
activated neurohormonal systems
activated t cells
activating myocardial pde2
activators
active individuals
activity
acute and outpatient settings
acute autonomic nervous system modulation
acute care surgery
acute coronary syndromes
acute decompensated hf
acute dyspnea
acute heart failure
acute heart failure clinical trials
acute heart failure complicating precapillary pulmonary hypertension
acute heart failure trial
acute hf
acute hf trials
acute ischemic right heart failure
acute kidney injury
acute myocardial infarction
acute pulmonary embolism
acute right heart failure
acute rv decompensation
acute rv failure
acute treatment
ad-c
ad-flk
ad-flk rats
adaptive
adenine nucleotides
adenoviral vector
adenyl cyclase
adherence to prescribed therapy
adipokines
adiponectin
adipose tissue
adjunctive treatment
adjusted hazard ratios
adjusted means
adjusted median rate ratio
adjuvant setting
administratie databases
admission median bnp levels
admission nt-probnp
admission to discharge
advanced chronic obstructive pulmonary disease
advanced copd
advanced heart failure
advanced heart failure therapy
advanced human hf
advances in treatment
adverse cardiovascular
adverse event rates
adverse events
adverse outcomes
aerobic
aerobic capacity
aerobic exercise
aerobic exercise training
aerobic training
af
af ablation
af patients
af type
af-free probability
african americans
afterload burden
age- and sex-adjusted risk
aggressive dose uptitration
aggressive medical treatment
aggressive protocols
aging
aha
ahf
ai
aim
air pollution
akt
albumin level
albumin levels
alcohol related
aldactone evaluation study
aldosterone antagonism
aldosterone antagonist
aldosterone antagonist eplerenone
aldosterone antagonist therapy
aldosterone blockade
aldosterone receptor antagonists
alendronate
alendronate- etidronate-
algorithms
all-cause
all-cause medical hospitalization
all-cause mortality
allopurinol
allopurinol rats
alphalisa immunoassays
alphalisa® immunoassays
altered protein kinase
ambient air pollution
ambulatory heart failure trial
ambulatory icd patients
ambulatory patients
america college of physicians
american college of cardiology
american heart association
american heart association guidelines on evaluation
ami
ami mortality rates
ami patient
amino-terminal pro-b-type natriuretic peptide
amyloidotic pattern
anaerobic metabolism
anaerobic threshold
anand
anemia
anemia treatment
anemic
ang ii infusion
ang ii infusion mouse model
angeli's salt
angii
angina
angiogenesis
angiography
angioplasty
angiotensin converting enzyme inhibitor
angiotensin converting enzyme inhibitors
angiotensin ii
angiotensin ii infusion
angiotensin ii receptor blocker
angiotensin receptor antagonist valsartan
angiotensin receptor blockers
angiotensin receptor neprilysin inhibitor
angiotensin receptors blockers
angiotensin-converting enzyme inhibitor
angiotensin-converting enzyme inhibitors
angiotensin-receptor
angiotensin-receptor blockers
angiotensin-receptor neprilysin inhibitors
ankle-brachial index
ann arbor veterans affairs hf clinic
annular size reduction
anoop shah
ans mice
antagomir evoked spontaneous cardiac dysfunction
antagonists
anterior leaflet opening
anthracycline
anthracycline metabolism
anthracycline-containing chemotherapy
anthracycline-induced cardiotoxicity
anthracycline-related congestive heart failure
anthracycline-treated breast cancer patients
anti-neoplastic agent
anti-oxidant defence
antiadrenergic therapeutic strategy
antiarrhythmic drugs
antiarrhythmic medication
antibodies targeting nonglycosylated
antibodies targeting the extreme n
anticoagulants
anticoagulation
antihyperglycemic agents
antihyperglycemic drugs
antihypertensive medication
antiplatelet agents
antiplatelet drugs
aortic blood flow
aortic insufficiency
aortic pressure curve
aortic valve insufficiency
aortic valve oversewing
aortic valve procedures
aortic valve repairs
aortic valve surgery
aortocaval fistula
apex
apical
apical rotation
apoptosis
apoptotic cells
apoptotic signaling pathway
appendicular lean mass index
arg16/ gln27
arginine vasopressin
aric
aric hf model
arm cuff
arni
arni inhibitors
arrhythmia
arrhythmia substrate
arrhythmia-related costs
arterial compliance
arterial elastance
arterial tonometry study
associated treatment strategie
astronaut
asymptomatic pediatric fontan
at
at1 receptors
atheromatous coronary disease
atherosclerosis
atherosclerosis risk
atherosclerosis risk in communities
atherosclerotic cad
atp
atp demand
atrial fibrillation
atrial fibrillation/flutter
atrial natriuretic peptide
atrial structure
atrial tachyarrhythmias
atrioventricular delay
attention control
auc
augmented cyclic guanosine monophosphate
augmented feedback
auscultation
autonomic balance
autonomic dysbalance
autonomic modulation
autonomic nervous system
avd
avp
b act via activation of vegf pathway
b on cardiac function
b treatment
b-treated
b-type natriuretic peptide levels
b-type np
band of activated caspase
baroreflex activation therapy
baroreflex sensitivity
barriers
barriers to exercise score
basal heart rate
basal rotations
baseline
baseline glomerular filtration rate
baseline hgb
baseline hrqol
bat
bat n-terminal pro-brain natriuretic peptide
bax
bb
bb therapy
bcl-2
bcl-2 mrna expression
bcl-2 proteins
bcl2
beagle dogs
beat-to-beat qt interval
beck depression inventory
behavioural-change interventions
best quintile of performance
bet bromodomain-containing protein 4
bet family bromodomain proteins
bet inhibition suppresses a pathological cardiac gene expression programme
beta blockade
beta blockers
beta receptor blockers
beta-blocker dose
beta-blocker therapy
beta-blockers
beta1-adrenergic receptor
bets
bhlh
bhlh transcription factor hand2
bioc
bioinformatic analysis
biological phenotype
biomarker
biomarker approach to predict heart failure risk
biomarker studies
biomarker-guided clinical trial
biomarker-guided clinical trials
biomarkers
biomedical reasons
biomedical treatment
bioprosthetic aortic valve replacement
bioprosthetic valve replacement
biosynthetic enzymes
bisoprolol
bisphophonates
bisphosphonate users
bisphosphonates
biventricular dysfunction
biventricular pacing
biventricular support
bivp
bivp setting
black ethnicity
black patients
black race
blacks
bleeding
blinded core laboratory
blood pressure
blood pressure control
blood transfusions
blood urea nitrogen
blood work drawn
blunted cardiac β-ar responsiveness
blunts beta-adrenergic responses
bmi
bnp
bnp levels
bnp measurements
body composition
body fat distribution
body mass
body mass index
bolus
bone morphogenetic protein
bottleneck stent
bottleneck stent model
bottleneck stenting
bradyarrhythmias
bradycardia induced
brain natriuretic peptide
brd4)
breast cancer
breast cancer patients
breath-holding
breathing control
bridge to recovery in infarction-related refractory right heart failure
bridge to transplantation
bridging therapy
bromodomain inhibition halts heart failure
bromodomain proteins
btes
btt
bundle branch block electrical activation
bundle-branch block
burden of heart failure hospitalizations
c d hf
c gmp
c statistic
c termini
c'd
c-index
c-kit+ cell differentiation
c-kit+ cell phenotype
c-kit+ cell yield
c-kit+ cells
c-statistics
c-terminally processed forms
c57bl/6 male mice
c=24.3
ca(2+) handling
ca(2+) influx
ca(2+)-uptake
cachectic heart failure patients
cachexia
cad
calcineurin/nfat signalling
calcium-sensitizing agents
calf muscle
calif
california office of statewide healthplanning and development patient discharge data
caloric restriction
calreticulin
camp
camp hydrolysis mediating a negative cross talk
camp hydrolytic activity
camp levels
camp production
camp-dependent protein kinase
campbell collaboration
canadian cardiovascular society
cancer
candesartan in heart failure assessment
canine model
capillary
cardiac
cardiac amyloidosis
cardiac angiogenesis
cardiac apoptosis
cardiac arrest
cardiac autonomic balance
cardiac benign tumors
cardiac c-kit+ cells
cardiac cachexia
cardiac catheterization
cardiac chromatin
cardiac comorbidities
cardiac death
cardiac diameters
cardiac dysfunction
cardiac energy metabolism
cardiac events
cardiac explant c-kit+ progenitors
cardiac explant-derived cells
cardiac fibrosis
cardiac filling
cardiac filling pressures
cardiac function
cardiac functions
cardiac gene control
cardiac genes
cardiac growth
cardiac hypertrophic response
cardiac hypertrophy
cardiac hypertrophy secondary to pressure-overload
cardiac index
cardiac injury
cardiac insulin-resistance
cardiac irs1
cardiac looping
cardiac magnetic resonance
cardiac magnetic resonance imaging
cardiac magnetic resonance postcontrast
cardiac magnetic resonance postcontrast t1 time
cardiac magnetic resonance t1 mapping
cardiac mena deletion
cardiac mrna levels
cardiac murmurs
cardiac myocyte-specific mena overexpression
cardiac na+ current
cardiac nurses
cardiac output
cardiac overexpression
cardiac pathophysiology
cardiac patients
cardiac performance
cardiac plasma membrane levels
cardiac procedures
cardiac rehabilitation
cardiac remodeling
cardiac resynchronization
cardiac resynchronization therapy
cardiac sodium current
cardiac specialty hospital
cardiac stress
cardiac sympathetic activity
cardiac sympathetic tone
cardiac symptoms
cardiac tissue
cardiac transplant
cardiac transplant recipients
cardiac transplant survival
cardiac transplantation
cardiac troponin t
cardiac vagal
cardiac vagal tone
cardiac vegf expression
cardiac volume overload
cardiac-resynchronization therapy
cardio failure
cardiogenic shock
cardiologist
cardiologists
cardiology
cardiology practices participating in the national cardiovascular disease registry practice innovation
cardiology services
cardiology-cardiovascular surgery consensus report heart failure
cardiomyocyte bioenergetics
cardiomyocyte-like cells
cardiomyocytes
cardiomyopathic restriction
cardiomyopathy
cardiomyopathy origin
cardioprotection
cardioprotective effect
cardioprotective signaling
cardiopulmonary
cardiopulmonary exercise
cardiopulmonary exercise test
cardiopulmonary exercise testing
cardiopulmonary exercise variables
cardiopulmonary resuscitation
cardiorespiratory fitness
cardiotoxicity
cardiovascular
cardiovascular complications
cardiovascular death
cardiovascular disease
cardiovascular diseases
cardiovascular event rate
cardiovascular events
cardiovascular function
cardiovascular health
cardiovascular hospitalization
cardiovascular mortality
cardiovascular outcomes
cardiovascular reserve
cardiovascular risk factors
cardiovascular system
cardiovascularverter defibrillators
cardioversions
cardioverter-defibrillator device
care management
carotid bodies
carotid intima-media
carvedilol
case-control study
caspase 3
caspase-3
caspase-3 activity
caspase-3 gene expression
catabolic isoenzymes
catabolic/anabolic imbalance
catalytic
catheter ablation
catheter ablation for af
catheter-based percutaneous revascularization
cav1.2
cav1.3
cav1.3 channels
cc
cd133+ cells
cd34+vegfr2+ cells
cdp choline
ceballos
cell
cell adhesion genes
cell senescence
cell therapy
cellular dysfunction
cellular plasticity
centers for medicare and medicaid
centers for medicare and medicaid services
centers for medicare and medicaid services demonstration
central blood pressure
central venous pressure
centre for reviews and dissemination
centrifugal flow pump
centrimag right ventricular assist device
centrimag rvad
cf
cf devices
cf lvad patients
cfa
cfi
cgmp
cgmp synthesis
ch
chagas' disease
chamber patterning
charm programme
chart review
chelation choices
chelation regimens
chemotherapy
chemotherapy-induced heart failure
chf
chf after hct
chf atrial explants
chf intubation rates
chf patients
chf predictive model
chf treatments
chf visit rates
chf-developed infarcted animals
chf-dnx
chf-inv
chf-inv group
chf-inv rabbits
chf-nyha-iii
chf-nyha-iiib
childhood malignant disease treatment strategies
chinese herbal medicine
chm
chop
chordal ruptures
chrmatin-associated proteins
chromatin
chromatin hyperacetylation
chromatin remodeling events
chromatin structure
chromatin subproteome
chromatin subproteomes
chromatin-associated proteins
chromatin-dependent signal transduction
chromatin-mediated signal transduction to pol ii
chronic
chronic acf
chronic advanced heart failure patients
chronic decompensated heart failure
chronic disease
chronic end-stage heart failure
chronic heart failure
chronic heart failure chronic heart failure
chronic heart failure induced
chronic hf
chronic hf-ref
chronic hfpef
chronic inflammatory state
chronic insulin exposure
chronic kidney disease
chronic kidney disease epidemiology collaboration equation
chronic myocardial ischemia
chronic obstructive pulmonary disease
chronic pah
chronic pulmonary arterial hypertension
chronic renal failure
chronic stable guideline-directed medical therapy
chronic systolic heart failure
chronically instrumented new zealand white rabbits
ci
ci=0.97-0.98)
ciaraldi
cinahl
circulating cd34
circulating fragments
circulating mediator
circulating nt-probnp
circulating nt-probnp concentration
circulating plasma ne
circulating progenitor cells
circulatory arrest
circulatory assist device
circulatory derangement
circulatory support
circumferential shortening
cis
ckd
class i
class ii heart failure
class iii
clcnka
clcnka gg genotype
clcnka polymorphism
clin
clinical
clinical benefit
clinical composite response
clinical diastolic dysfunction
clinical doppler echocardiography
clinical excellence registry
clinical modification codes
clinical outcome
clinical outcomes
clinical prediction rule
clinical status
clinical trial registries
clinical trials
clinics
cms
cms metrics
cncka snp
co
co correlated
co-activating transcription factor networks
co-morbidities
cochrane databases
cochrane effective practice
cochrane library
cognitive function
cognitive impairment
cohort
collagen cross-linking
collagen density
collagen deposition
collateral growth
colon
comanagement
commissie
community outpatient settings
comorbidities
compensated hfpef
compensated lv hypertrophy
compensatory hypertrophy to cardiac failure
competing priorities
competitive collateral
complication
complications
computed tomographic angiography
computing readmissions
concentric hypertrophy
concentric remodeling
concordance c statistics
concurrent hf
conditional gene-targeted hand2 mice
confidence interval
confirmatory factor analysis
congenital abnormalities
congenital accessory pathways
congenital heart lesions
congestion-like
congestive heart failure
congestive heart failure exacerbation
congestive heart failure patients
congestive heart failure phenotypes
congestive heart failure trial
congestive heart failure visits
conscious
conscious dogs
conscious hf rats
conscious rabbits
consensus report
consenting ambulatory hf patients
consultations
contemporary heart failure
contemporary therapeutic options
content-driven telehealth system
content-driven telehealth technology
continuous flow
continuous wave doppler echocardiography
continuous-flow lvads
contractile efficiency
contractile function
contractility
contrast agent
contrasting groups
control adenovirus
control group
controlled randomized trials
controlled trial investigating outcomes of exercise training
controlling heart rate
copd
coprimary end points
coral
coronary angiography
coronary artery bypass grafting
coronary artery bypass surgery
coronary artery calcium scores
coronary artery disease
coronary artery ligation
coronary disease
coronary heart disease
coronary interventions
coronary microembolization-induced hf
coronary occlusion
coronary perfusion
cost
cost-effectiveness
costs
cox hazard models
cox model
cox model analysis
cox models
cox proportional hazard analyses
cox proportional hazard models
cox proportional hazards analyse
cox proportional hazards models
cox proportional hazards regression modeling
cox regression
cox regression analysis
cox regression models
cox-proportional hazard models
cpcs
cpet guiding exercise rehabilitation
cpg recommendations
cpg-recommended pharmacological treatment
cpgs
cpr
cr
creatine kinase activity
creatinine
crf
crf distribution
cronbach
cross-sectional
crt
crt group
crt implantation
crt off
crt on
crt on assignment
crt-d
crt-d recipients
crude
crude 28-day case-fatality rate
crude rates
crude rr
cs
ctnt
cultured cardiomyocytes
cumulative urine volume
cv
cv death
cv deaths
cv events
cvd
cxl-1020
cxl-1020 contractility
cxl-1020 converts
cxl-1020)
cyclic adenosine monophosphate
cystatin c level
cytochrome c
cytoscape
cytoskeletal actin dynamics
cytotoxic effect
czech republic
cα
dacron patch closure
danish heart failure database
danish registry on dialysis
dapc
dapc protein levels
dash
dash diet
dash diet scores
dash/srd
dash/srd reduced clinic
dcm
dd
deactivation
death
debilitating stroke
decompensated hf
decompensated systolic heart failure
decongestion
decongestion end point
decoy vegf receptor
decrement
defibrillator
defibrillator-only therapy
deficit index
degenerative mitral regurgitation
degenerative mitral valve
degenerative mr
degs
denmark
depressed left ventricular
depresses
depression
depressive symptoms
deranged ca(2+) handling
derivation cohort
descriptive assessment
descriptive research
desensitizes against acute β-ar stimulation
design
destination therapy
detergent
development and evaluation
device
device consideration
device implantation
devices
diabetes
diabetes mellitus
diabetes status
diabetic zsf1 rats
diagnosed
diagnosis
diagnostic approaches
diagnostic performance
diagnostic procedure
dialysis patients
dialysis-dependent patients
diameter stenosis
diastole
diastolic blood pressure
diastolic dysfunction
diastolic failure
diastolic filling formalism
diastolic filling time
diastolic function
diastolic indices
diastolic mitral leaflet motions
diastolic mitral valve tethering
diastolic properties
diet
diet adherence
diet group
diet score components
dietary approaches to stop hypertension
dietary interventions
dietary recommendations
dietary sodium restriction
differential g-protein coupling
diffuse myocardial changes
dilated cardiomyopathy
dilated lv
dimension index
dipeptidyl peptidase-4
direct observation
direct renin inhibitors
disappearance
discharge
discharge patients
discrimination
disease management
disease management programs in heart failure
disease progression
disease recapitulates
disease risk score
diseased human
disturbed intestinal barrier
dithiothreitol
diuretic
diuretic efficacy
diuretic peptides
diuretic refractory severe-end-stage hf
diuretic resistant volume overload
diuretic response
diuretic use
diuretics
dna
dna fragmentation
dnx
dobutamine
doctors
dodson et al
dopamine
doppler early diastolic mitral annulus velocity
doppler echocardiography
doppler mitral inflow velocity
doppler ultrasonography
dose uptitration
double-blind
downregulation
downstream signaling
downstream signalling
doxorubicin
doxorubicin cardiotoxicity
doxorubicin efflux transporter abcc2
doxorubicin in vitro
doxorubicin treatment
doxorubicin-induced cardiotoxicity
doxorubicin-induced heart failure
dpp-4
dpp-4 inhibitors
driveline infection
driveline injury
drs deciles
drs-stratified analyses
drs-stratified hazard ratios
drug abrogated
drug-free
drug-untreated failing hearts
drugs
dt
dtt
dual energy x-ray absorptiometry
dual x-ray absorptiometry
dual-energy x-ray absorptiometry
duration
dxa
dynamic
dysfunction
dyslipidemia
dyspnea
dyssynchronous failing heart
dyssynchronous heart failure
dyssynchronous hf
dyssynchronous nonfailing
dystrophin-associated protein complex
e-lateral
e-septal
e-septal correlated
e-wave
e/e
e/e'lateral
e/e'mean
e/elateral
e/emean
ea
early diastolic mitral annular velocity
early medical management
early physician follow-up after discharge
early transmitral blood flow velocity over tissue
early transmitral flow
early-outgrowth colony-forming units
east
ec
ec coupling
eccentric hypertrophy
eccentric versus concentric left ventricular hypertrophy
ecct
ecct patients
ecg
ecg parameters
ecgs
echo-doppler cardiography
echo-doppler studies
echocardiograms
echocardiographic
echocardiographic assessment
echocardiographic evidence
echocardiographic examina
echocardiographic measurements
echocardiographic measures
echocardiographic predictors
echocardiographic score
echocardiography
echocardiography evaluations
ecmo
ecmo group
ecmo+vad group
ecmo+vad groups
economic analysis
economic climate
economic impact
economische evaluations
economische models
ecs
ed
ed patients
ed physicians
ed visits
ed volume
edge-to-edge anastomosis
ees
ef
effects of care management
efficiency
egfr
egfr group ii
egfr group iii
egfr group iv
egs ratio
eh
eh denotes
ehrlich carcinoma
ejection fraction
ejection fractions
elastic n2 bus segment
elderly
electrocardiographers
electrocardiographic device
electrocardiographic q waves
electrolytes
electromechanical behavior
electromechanical delay
electron microscopy
electronic databases
elektrial activation
elevated left atrial pressure
elevated resistin
eligibility
embase
embryonic gene programs
embryonic gene programs in heart failure
emd
emd prolongation
emergency cardiac catheterization
emergency department
emergency department (ed
emotional status
emotional stress
emphasis-hf
emphasis-hf study
end stage heart failure heart failure
end-diastolic volume
end-diastolic volume index
end-stage congestive heart failure
end-stage heart failure
end-stage renal disease
end-systole
end-systolic elastance
end-tidal co2
endoplasmic reticulum
endothelial cell
endothelial dysfunction
endothelial function
endothelial no synthase activation
endothelial repair
endothelial-protective effects
endothelin
energie expenditure
energy deficit
energy metabolism
energy substrate metabolism
english-language trials
enos-ser(1177
enos-thr
enrollment
enrollment period
eo-cfus
eov
ephesus
epicatechin-rich cocoa
epidemiology
epifluorescence microscopy
epigenetic
epigenetic readers in cardiac biology
epinephrine
epithelial to mesenchymal transition markers
eplerenone
eplerenone in mild patients hospitalization
eplerenone post myocardial infarction heart failure efficacy
erasers
erc
erc induced recovery/enhancement
erk1/2 molecular scaffolds
erk1/2 signalling
erythropoiesis-stimulating agent therapy
erythropoiesis-stimulating agents
esc advocate
eseptal
esmolol
esrd
et
et on hdl-mediated protective effects
ethically complex situations
ethics rounds
etidronate
etiologic causes
etiology
eu
eu/va/va-rt cohorts
europese retrospective cohort study
europese society of cardiology guidelines
euthanization
evidence based practice centres
evidence-based care in heart disease evaluated
excitation-contraction
exercise
exercise adherence
exercise and medical therapies to improve cardiac function
exercise capacity
exercise duration
exercise group
exercise intolerance
exercise oscillatory ventilation
exercise performance
exercise programmes
exercise rehabilitation
exercise tolerance
exercise training
exercise training on hrqol
exercise training response
exercise-induced pasp
exercise-induced pulmonary artery systolic pressure
exertion
exogenous variants
expenditure
expenditures
experimental hf
extending emd
external validity
extra corporeal membrane oxygenation
extracellular flux analyzer
extracellular matrix
extracorporeal life support
extracorporeal membrane oxygenation
extracorporeal membrane oxygenation membrane support
extracorporeal support
extubated
factors predicting survival
failing fontan
failing heart
failing hearts
fat
fat mass
fat mass index
fatal
fatty acids
fes
ffm
fiber/sheet orientation
fibrosis
figuur
figuur profiling
filling pressures
fit
fit men
fixed-rate atrial pacing
flow-mediated dilatation
flow-mediated dilatation diameter
fluorescence resonance energy transfer-based assays
fm
follow-up
follow-up exercise capacity
follow-up measurement
follow-up medication
fontan circulation
fontan failure
force generated
fpassive
fractional flow reserve
fractional shortening
frail
frailty
framingham
framingham heart study criteria
free wall cs
free wall rs
free-breathing pulse sequennce
full medicare coverage
full-length scn5a
fully magnetically levitated lvas
function
function in vitro
functional capacity
functional class iii hf
functional class nyha ii-iii
functional decline
functional deficits
functional efficacy
functional electrical stimulation
functional enrichment analysis
functional mitral stenosis
functional ms
functional status
furosemide dose
futility
g
g-protein-coupled receptor kinase-2
g-protein-coupled receptors
gastrointestinal
gastrointestinal bleeding
gating movement
gdmt
gdmt-treated nyha functional class iii hf
gem/kir
gene expression omnibus
gene expression profile gse9128
genetic
genomic reprogramming events
gill index
global gene expression
global left ventricular longitudinal systolic strain
global longitudinal strain
global proteomics
glomerular filtration
glomerular filtration rate
gls
gls outperformed left ventricular ejection fraction
glucose
glucose oxidation
gly16/ glu27 haplotype
glycolysis
glycolysis/gluconeogenesis
goal-directed lipid-lowering therapy
grade
grading of recommendations assessment
gross income
gross national income per capita
guideline recommendations in heart failure
guideline-recommended drugs for heart failure
guideline-recommended medications
guideline-recommended treatment
guidelines-heart failure
gut
h-dko mice
haard ratio
habc battery
habc battery score
habc battery scores
haematopoietic cell transplantation
haemodynamic
haemodynamic stress
hand grip strength
hart
hart enrolled patients
hazard ratio
hazard ratios
hct
hdl
hdl function
hdl particles
hdl-induced no production
health abc hf model
health abc hf risk model
health abc short physical performance battery
health behaviors
health buddy program
health care expenditures
health insurance
health per capita
health status
health system data partners
healthcare utilization
healthstar
healthy cardiomyocytes
healthy control
healthy heart muscle cells
healthy volunteers
heart
heart block
heart dilatation
heart disease
heart failure
heart failure adherence
heart failure admission
heart failure aldosterone
heart failure clinic
heart failure cost-effectiveness model
heart failure discharges
heart failure disease management programs
heart failure guidelines
heart failure home
heart failure hospitalization
heart failure index
heart failure mice model
heart failure mortality
heart failure myocardial tissue
heart failure nurse practitioner
heart failure nurses
heart failure patient severity index
heart failure patients
heart failure prone to ventricular tachycardia
heart failure rats
heart failure risk
heart failure survey in israel
heart failure t1-mapping values
heart failure treatment
heart failure-related hospitalization
heart magnetic resonance imaging
heart pathology
heart rate
heart rate reduction
heart rate response
heart rate variability
heart rate variation
heart t2
heart team
heart transplant
heart transplant recipients
heart transplantation
heart transplantations
heartmate
heartmate ii
heartmate ii exchange
heartmate ii insertion
heartmate ii lvad
hearts
heartware
heartware intl
hek
helix-loop-helix
hemocompatibility
hemodynamic
hemodynamic alterations
hemodynamic disorder
hemodynamic phenotype
hemodynamic status
hemodynamically
hemodynamically stable
hemodynamically unstable
hemoglobin
hemoglobin levels
hemostasis
henry
hepatic function
hereditary
heterochromatic chromatin
heterogenous improvement
hf
hf admissions to acute hospitals
hf canine electromechanics
hf clinic outpatients
hf complicating ami
hf disappeared
hf enrolled in the heart failure
hf epidemiology
hf guidelines
hf hospital admissions
hf hospitalisations
hf hospitalization
hf hospitalizations
hf induced in mice via phenylephrine
hf model
hf mortality
hf mortality risk
hf pathogenesis
hf patient plasma
hf patients
hf prediction model
hf progression
hf rats
hf registry
hf remodeling aspects
hf risk
hf risk factors
hf risk prediction
hf studies
hf symptom
hf units
hf volume management
hf-action
hf-action cohort
hf-induced remodeling
hf-ref
hf-related cachexia
hfpef
hfpef patients
hfpsi
hfpsi model
hfref
hfvt
hg
hgb
hgb level
hh
hhd
hhf
hierarchical regression models
high-fat diet
high-risk patient
high-risk patients
high-volume physicians
hipsc-cms
histone acetyltransferases
histone deacetylases
hm
hm ii
hno
hno donor
hnorm group
hogan
holosystolic murmur
home telemonitoring
hoog-cost medicare fee-for-service beneficiaries
hoog-volume physicians
hospital
hospital compare
hospital days
hospital discharge
hospital quality improvement initiative
hospital rates
hospital volume
hospital volume groups
hospital-based programmes
hospitalisation
hospitalisation for heart failure
hospitalisations for heart failure
hospitalization
hospitalization for heart failure
hospitalizations
hospitalized
hospitalized heart failure
hospitalized hf
hospitalized older adults
hospitalized patients
hospitals
hr
hr dynamics
hr per kg/m(2)
hr reduction
hr variability
hr variability/turbulence
hr=0.931
hr=1.02
hretn
hrqol
hrv
hscrp
hum-retn mice
hum-retn mice treated
human embryonic kidney
human heart failure
human induced pluripotent stem cell-derived cardiomyocytes
human myocardial tissue
human rad q66p
human resistin
humanized male mice
humanized mouse model lacking murine resistin
humoral stimuli
hungary
hvad devices
hybrid system
hyperinsulinemia
hyperkalemia
hyperlipidaemia
hypertension
hypertensive
hypertensive heart disease
hypertensive heart failure
hypertensive hfpef
hypertensive lv dysfunction
hypertrophy
hypoalbuminemia
hypokalemia
hypotension
hypoxia
i
i-meta-iodobenzylguanidine
i-mibg
i-mibg cardiac washout
i-mibg myocardial washout
ic
icc
icd patients
icd shocks
icd-hf patients
icds
icu admission
icu mortality
idealized lv end-diastolic pressure
idiopathic dilated cardiomyopathy
idiopathic dilated cardiomyopathy cohort
idiopathic-dilated cardiomyopathy
ie
ies
if inhibitor ivabradine trial
if-channel inhibition
ii
iii
il6
immunoblotting
immunodetection
immunohistochemistry
immunoprecipitation
immunoreactive nt-probnp
impaired right ventricular pump function
implantable cardiac arrhythmia devices
implantable cardiac defibrillator
implantable cardioverter defibrillator-crt
implantable cardioverter defibrillators
implantable cardioverter-defibrillator
implantable cardioverter-defibrillator deactivation
implantable cardioverter-defibrillator deactivation preferences
implantable cardioverter-defibrillator device
implantable cardioverter-defibrillator therapy
implantable cardioverter-defibrillators
implantable defibrillators
implanted monitoring devices
in vivo coronary perfusion
in vivo inhibition
in vivo rv length-force relationship
in-trial resource utilization
inactive cxl-1051
inappropriate atp
inappropriate implantable cardioverter-defibrillator therapy
inappropriate shock therapy
inappropriate therapy
incessant ventricular tachycardia storm
incidence and mortality outcomes
incident cardiovascular events
incident hf
index
index admission
index ami
index beat method
index ed visit
inducible myocardial ischemia
industrial areas
infarct size
infarcted hearts
infarcted rats
infarction
inferior vena cava
inflammation
inflammation-stimulated resistin levels
inflammatory
inflammatory abdominal problems
inflammatory biomarkers
inflammatory markers
inflammatory stimuli
ingenuity pathway
inhibit cardiac l-type channel activity
inhibiting tgf-β receptor type i
inhibition
inhibition of vascular endothelial growth factor
inhibitor jq1
inhibitors
inhibitory actions
inhospital mortality
inhospital outcomes
inimpaired lv relaxation
inmuscular testosterone supplementation
inoperable chronic thromboembolic pulmonary hypertension
inotropes
inotropic
inotropic effect
inpatient admissions
inpatient assessments
inpatient medical conditions
inpatient records
inpatients with heart failure
insights from heart failure
insulin action
insulin products
insulin receptor substrates
insulin resistance
insulin-signaling components regulating cellular metabolism
insulin-stimulated rates
intact hearts
integrated discrimination improvement
interaction term analysis
interagency registry for mechanically assisted circulatory support
interatrial shunt
interleukin receptor family member st2
intermediate frailty
intermediate metabolism
internal reliability
international classification of diseases
international right heart foundation working group
interne
interne consistency
interquartile range
interventions
interventricular delay
interventricular septum biopsies
intestinal dysfunction
intestinal morphology
intolerance
intraclass correlation coefficient
intravenous atropine
intravenous inotropes
intravenous iron
intravenous metoprolol
intubation rates
intubations
invasive hemodynamic
invasive hemodynamic assessment
ion channelopathies
ip
iron
iron deficiency
iron homeostasis
iron-deficient adult patients
irs1
irs2
irs2 double-knockout
irs2 proteins
ischemia
ischemic
ischemic cardiomyopathy
ischemic conditioning
ischemic etiology
ischemic events
ischemic heart failure
ischemic heart failure samples
ischemic hf pathogenesis
ischemic mitral regurgitation
ischemic mr
ischemic-hypertensive cardiomyiopathy
isoelectric focusing
isolated cardiomyocytes
isolated heart rate
isolated heart transplant
isolated heartmate ii
isolated heartmate ii lvad
isolated hr reduction
isoprenaline infusion
isoproterenol
italy
iv heart failure
iv hf
ivabradine
ivabradine group
ivabradine on exercise capacity
ivabradine unloads
ivc
ivc occlusion
japan
japanese heart failure patients
jehovah's witness
joanna briggs institut
jq1
jugular venous pressure
ka renal chloride channel gene
kansas city cardiomyopathy questionnaire
kansas city cardiomyopathy questionnaire summary
kaplan-meier analyses
kaplan-meier curves
kappa coefficient
kccq
kccq category
kccq domains
kccq overall summary
kccq overall summary scores
kccq scales
kccq summary scores
kcl-ki treatment
kidney failure
kidney index score
kidney infection
kidney injury
killip class
kinases
kosten
kosten-effective
kv4.3 channel mrnas
kv4.3 mrna levels
kwh
l-dko
l-dko mice
l-type ca2
l-type ca2(+) current amplitude
l-type ca2+ currents
l-type channel isoforms
l-type currents
la
label-free shotgun proteomics
lack of hypertension
lactate
lad
lad model
lad models
lager
lager exercise time
lancet
latin america
lbbb
lcx
lcx model
ldl-cholesterol
leaflet configurations
leaflet motion
leaflet repair
lean body mass
lean mass
lean mass quantification
lean zsf1
lean zsf1 group
left
left atrial area
left bundle branch block
left heart twist
left ventricle
left ventricle end-diastolic pressure
left ventricular
left ventricular assist device
left ventricular assist device implantation
left ventricular assist devices
left ventricular assist system
left ventricular base
left ventricular biopsies
left ventricular dd
left ventricular diastolic end diameter
left ventricular diastolic function
left ventricular dilatation
left ventricular dysfunction
left ventricular dyssynchrony
left ventricular ejection
left ventricular ejection fraction
left ventricular ejection time
left ventricular end-diastolic pressure
left ventricular filling
left ventricular filling pressure
left ventricular filling pressure response to exercise
left ventricular function assessment
left ventricular longitudinal systolic strain
left ventricular mechanics
left ventricular midpapillary level
left ventricular systolic dysfunction
left ventricular tissue
left-hand grip strength
leg strength
length-force relationship
leu3-gly4
lf/hf ratio
liberal transfusion protocols
life score
life-sustaining treatment
limitation
lipolysis
lipoprotein
lipoprotein-associated phospholipase a2
literature
literature search
littermate controls
liver disease
log-rank testing
log2 ng/ml
logistic analysis
logistic regression models
lokomat® system
long-term clinical outcomes
long-term costs
long-term mortality
long-term survival
longitudinal rv fiber shortening
loop diuretics
low crf categories
low left ventricular ejection fraction
low left ventricular ejection fractions
low testosterone status
low-dose bb
low-dose dopamine
low-dose nesiritide
low-frequenncy/high-frequenncy
low-volume ed cases
low-volume eds
low-volume physicians
lower body mass index
lower cd34+vegfr2+ cells
lower exercise performance
lower lvef
lower mortality
lp-pla2
lp-pla2]
lung weight
lusitropic
lv
lv assist device
lv assist device implantation
lv assist device implantations
lv compliance
lv diastolic dysfunction
lv diastolic stiffness
lv dilatation
lv dysfunction
lv ef
lv ejection fraction
lv end-diastolic dimension
lv end-diastolic pressure
lv end-diastolic pressure/wall stress
lv end-diastolic volume
lv end-systolic volume
lv fibrosis
lv filling pressure
lv filling pressures
lv fractional shortening
lv function
lv hypertrophy
lv internal diameter
lv posterior wall thickness
lv remodeling
lv reverse remodeling
lv strain
lv strain rate
lv structure
lv systolic indices
lvad
lvad implantation
lvad support
lvad surgery
lvad therapy
lvads
lvas
lvas support
lvef
lvet
lvet carries prognostic value
lying
lyso-paf acetyltransferase
lyso-paf-at
macrophages
madit-crt
madit-crt trial
magnet(®
magnetic resonance angiography
magnetic resonance spectroscopy
magnetically levitated centrifugal-flow chronic lvas
magnetically levitated left ventricular assist system
magnetically levitated rotor
main outcome
maisel
maladaptive cardiac remodelling
maladaptive molecular processes
maladaptive remodelling
male sex
males
malfunctioning heartmate ii lvads
malondialdehyde
malondialdehyde bound to hdl
mammalian enabled
management
management strategies
markers
mass spectrometry
massive embolism
maximal cardiopulmonary exercise test
maximum o2 consumption rate
mdc
mdc95%
mean
mean ejection fraction
measuring np levels
mechanical
mechanical cardiac support
mechanical circulatory support
mechanical dyssynchrony
mechanical support devices
mechanistic insight
median age
median baseline st2 level
median body mass index
median follow
median followup
median left ventricular ejection fraction
median rate ratio
medical management
medical outcomes
medical records
medical support
medical therapy
medical treatment
medical treatment guidelines
medicare
medicare fee-for-service
medicare fee-for-service beneficiaries
medicare hospital claims
medicare inpatient data
medicare patient safety monitoring system
medication
medication regimen
medications
mediterranean
medline
men
mena
mena expression
mena overexpression
messenger rna
metabolic enzymes
metabolic exercise
metabolic risk factors
metabolism
methodology
methods
methotrexate
methylatropine
metoprolol
metoprolol succinate
metoprolol treatment
metric
metric choice
mi
mi characteristics yielded hazard ratios
mi diagnosed
mi-induced decreases
microarray data
micrornas
micrornas in heart failure
mid lad
midpapillary
midregional proanp
mild heart failure
mild mr
mineralocorticoid receptor antagonists
minnesota
minnesota living with heart failure
minnesota living with heart failure questionnaire
mir-25
mir-25 expression integrate
mirnas
misdiagnosis
mitochondrial complex v activity
mitochondrial damage induced
mitochondrial dysfunction
mitochondrial energy production
mitochondrial function
mitochondrial oxidation
mitochondrial oxidative metabolism
mitochondrial oxidative phosphorylation
mitochondrial oxidative phosphorylation capacity
mitochondrial oxidative stress
mitochondrial proteome changes
mitochondrial respiration
mitochondrial structure
mitochondrial ultrastructural
mitochondrial-targeted
mitochondrial-targeted antioxidant
mitochondrial-targeted peptide ss31
mitral annulus velocities
mitral filling flow
mitral filling flow volume
mitral regurgitation
mitral stenosis
mitral stenosis reversed
mitral valve opening
mitral valve plasty
mixed linear models
ml/kg/min
ml/m2
mlhf
mlhf questionnaire
mlhf total score
model
moderate
modifiable risk factors
molecular biomarkers
molecular dysfunction
molecular mechanism
molecular pathways
monoclonal antibodies
monocytes
monomeric g proteins
monotype natriuretic peptide
morbidity
morpholino-based knockdown
mortality
mortality risk
mortality/hospitalization
mouse heart
mouse heart failure
mouse hf model
mouse myocardium
mouse rad q65p
mouse tac model
mouse ventricular myocytes
mpsms database
mr
mr-proadm
mr-proanp
mri
mri scanner
mri-based models
mrna levels
mrna splicing
ms
mt
multicenter
multicenter automatic defibrillator implantation
multicenter automatic defibrillator implantation with cardiac resynchronization therapy
multihospital study
multiorgan failure
multiple myeloma
multisystem disease
multivariable cox modeling
multivariable-adjusted hazard ratios
multivariate cox regression analyses
murine equivalent
murine myocardium to heart failure
murphy
muscle aerobic capacity
muscle strength
muscle strip stiffness
muscle strips
muscle-wasting syndrome
muscular strength
mutant mice overexpressing hand2
mva
myocardial collagen
myocardial dd
myocardial diastolic dysfunction
myocardial extracellular matrix
myocardial extracellular matrix accumulation
myocardial function
myocardial glycolysis
myocardial infarction
myocardial infarction-both
myocardial insulin resistance
myocardial ischaemia
myocardial ischemia
myocardial ischemic events
myocardial loss
myocardial oxygen consumption
myocardial pde2 expression
myocardial perfusion
myocardial phosphodiesterase-2
myocardial remodelling
myocardial t1
myocardial titin hypophosphorylation
myocarditis
myocardium
myocardium displays altered expression
myocyte
myocyte depolarization
myocyte diameter
myocyte hypertrophy antecedent to heart failure
myocytes
myofiber dynamics
myofiber shortening
myofiber shortening onset
myofiber shortening velocity
myofibre regeneration
myofibrillar ca(2+)-stimulated atpase activity
myofilament ca(2+) sensitivity
myosin binding protein-c phosphorylation
myxomas
n-
n-terminal fragment
n-terminal pro-b-type natriuretic peptide
n-terminal pro-b-type natriuretic peptides
n-terminal pro-b-type np
n-terminal pro-brain natriuretic peptide
n-terminal pro-brain-type natriuretic peptide assessment
n-terminal probnp
na+ channel mrna splice variants
na+ channels activate unfolded protein response
nanomolar doses
national medicare data
natriuretic peptide
natriuretic peptide levels
natriuretic peptide system
natriuretic peptides
natural vasodilatory
naviaux
nbdmard
nbdmards
nc
nc=235
negative binomial regression models
negative coronary angiography
neoangiogenesis
neonatal rat ventricular cardiomyocytes
nephrectomy
nephropathy
neprilysin blocks renin-angiotensin-aldosteron
neprilysin inhibition
neprilysin inhibitor prodrug
neprilysin inhibitors
nesiritide
net economic savings
net reclassification
network meta-analysis
neuro-hormonal system
neurohormonal abnormalities
neurohormonal activation
neurohormonal stimulation
neurohormonally induced heart disease
neurohormone
neurohormones
neurohumoral blockers
neurological
neuronal stressors
neutral endopeptidase inhibitors
new york heart association
new york heart association class
new york heart association class i to iii
new york heart association class i/ii fontan adults
new york heart association class ii
new york heart association class ii to iv hf
new york heart association class iii
new york heart association class iii heart failure
new york heart association classes i
new york heart association classification
new york heart association functional class
nf-κb
nfat
nhs
nicorandil
nicorandil ameliorates mitochondrial dysfunction
nights spent in hospital
ninth revision
nitric oxide
nitric oxide donors
nitrite
nitroxyl
nmol/l
no
no beta-blockers
noc outcomes
non-aas
non-biological disease modifying antirheumatic drug
non-cachectic chf
non-diabetic patients
non-dilated left ventricle
non-dnx
non-fatal stroke
non-frail participants
non-ischemic
non-ischemic heart failure samples
non-lbbb
non-linear hr variability
non-urbanized midwestern state
nonadherence
noncardiovascular diagnoses
noncardiovascular drugs
noncoding rnas
nondiabetes risk factors
nonfatal outcomes
nonischemic cardiomyopathies
nonpace
nonpace dnx
nonprescribing
nonselective
nonsurvivors
nontrastuzumab users
nontraumatic death
nontreatment
nordic walking
norepinephrine
norepinephrine-induced hypertrophic
normal geometry
northwest united states
np
np assessment
np levels
np measurement
nps
nt-probnp
nt-probnp assay targeting nonterminal epitopes
nt-probnp cutoff point
nt-probnp levels
nt-probnp testing
nuclear factor
nuclear factor-κb
nucleolin
nurse assessment
nursing outcomes classification
nursing terminologies
nursing-sensitive outcome
nursing-sensitive outcome change scores
nutrition
nutritional abnormalities
nutritional strategies
nuts
nyha
nyha class
nyha class iii
nyha classification
nyha functional assessment
nyha functional class
nyha functional class ii
nyha functional class iv
nyha functional class ranking
nyha-iiib
obese
obese older patients
obese participants
obese zsf1
obese zsf1 groups
obesity
odds ratio/hazard ratio
odds ratios
ods ratio
off-pump sternal sparing approach
oht
oht bridged to transplant
older adults
olmsted county
onderzoek
open chest model
open stent
open-label crossover study
optimal diuretic therapy
oral glucocorticoid dosage
oral glucocorticoids
organisation of care taxonomy
orthotopic heart transplantation
osprey
osteoporosis
outcome
outcomes
outpatients
overexpress scn5a variants
overstimulation
overweight
overweight body index strata
oxidative stress
oxidative stress markers
oxygen consumption
oxygen flow
oxygen pulse
p
p = .006
p = 0.008)
p.arg83gly
p3 prolapse
p38
p38alpha mapk
p38α mitogen-activated protein kinase
p70s6k
p<0.001
p=0.03
pace dnx
pace non-dnx
pacemaker
pacemakers
pacing-induced chf
pacing-induced dilated cardiomyopathy
paco2 cerebral blood flow
pad
paediatric cardiac transplants
paediatric heart failure
paf
paf levels
paf-acetylhydrolase
paf-ah
paf-cpt
pah
palliative care
paradigm shift
paradigm-hf
parasympathetic
parasympathetic activity
parasympathetic control
parasympathetic function
parasympathetic neurotransmission
parasympathetic tone
partial pressure
participatory
pasp
pasp increase
passive/stiffness
patent
pathobiology/pathophysiology
pathogenesis
pathological gene expression
pathological gene induction
pathological heart disease
pathological hypertrophy
pathophysiological origin
pathophysiology
patient
patient compliance
patient consultation
patient management interventions
patient management interventions in heart failure cost-effectiveness model
patient preferences
patient safety
patient safety initiatives
patient satisfaction
patients
patients hospitalized
patients hospitalized with heart failure
patients in heart failure
patients with heart failure
pay-for-performance
pb
pb characteristics
pb cycle
pcwp
pcwp estimation
pd
pd initiation
pde superfamily
pde2
pde2 activity
pde2 inhibition
pde2 overexpression
pde2)
pde2-mediated effects on beta-adrenergic receptor
pde2-overexpressing cardiomyocytes
peak early diastolic mitral flow velocity
peak o2 per kilogram
peak oxygen consumption
peak oxygen uptake
peak quadriceps force
peak vo2
peak vo2)
peak work rate
pediatrc heart failure
pediatric heart failure
pediatrics
pef
percutaneous coronary intervention
percutaneous coronary revascularization
percutaneous one-vesel model
performance
perfusion
peripheral arterial disease
peripheral artery disease
peripheral edema
peripheral muscle pump
peripheral muscles
peripheral oedema
peripheral vascular disease
periprocedural
peritoneal dialysis
perk
perk activation destabilized scn5a
perk inhibition
perkins
permeability
perturbed mitochondrial function
petco2)
pevk segment
pf
pf cohort
pf mean
pf-cpt
pg/kg/min
pg/ml
ph
pharmaceutically assisted
pharmacologic management
pharmacologic studies
pharmacologic therapies
pharmacologic treatment
pharmacological armamentarium
pharmacological treatment
phenylephrine-induced genes
phenylephrine-mediated hypertrophy
phosphocreatine
phosphodiesterase-2
phospholamban
phosphomimic ser77
phosphorylation
physical exhaustion
physical therapy
physician adherence
physician adherence to hf cpgs
physician continuity
physician follow-up
physician volume
physicians
physicians busy
physio ring 30
physiological proteolysis
pigs
pioglitazone
pka
pka subunits
pkc-βii
pkc-βii-ser
placebo
placebo-controlled clinical trial
plasma
plasma b-type natriuretic peptide
plasma collected
plasma membrane translocation
plasma n-terminal pro-b-type natriuretic peptide
plasma norepinephrine
plasma nps
plasma samples
plasticity
platelet-activating factor
pleasanton
pluripotency marker nanog
pna
pneumonia
poc measurement
poc systems
poc technology
point-of-care systems
policy recommendations
polymorphisms
poor myocardial function
poorer vo2 max
porcine model
portal hypertension
positron emission tomography imaging
post-acute care transfer policy
post-dash/srd brachial
post-hct chf
post-lvad
post-lvad ai
post-myocardial infarction heart
post-myocardial infarction heart failure patients
post-myocardial infarction patients
post-transplant morbidity
posterior wall infarction
posteriorly displaced papillary muscles
postexercise phosphocreatine resynthesis
postmarketing trials
postmenopausal women
postnatal mammalian myocardium
postoperative echocardiography
postoperative mortality
postoperative normalization
postoperative survival
postystolic
potassium
potential preventable readmission
power spectral analysis
ppr
practice settings
practice-level differences
practice-level variation
pre-crt lv
pre-hct exposure to anthracyclines
pre-hct germline dna
pre-pd
precapillary ph
precipitating factor
prediction rule
predictor
predictors
preoperative albumin
preoperative clinical characteristics
preoperative demographics
preoperative hypoalbuminemia
preserved
preserved cardiac index
preserved ef
preserved ejection
preserved ejection fraction
preserved left ventricular
preserved left ventricular ejection fraction
preserved lv ejection fraction
preserved lvef
preserved systolic function
pressure development
pressure gradient
pressure ulcers
pressure-overload hypertrophy
pressure-overload-induced heart failure
pressure-overload-induced hypertrophy
principal findings
prior stroke score
pro-adrenomedullin
pro6-gly7
proangiogenic effects
proces redesign contextual framework
prognosis
prognostic factors
prognostic meaning
prognostic power
programmed cell death
progression to heart failure
progressive disease
prolapse
prolonged electromechanical delay
pronto
proof-principle cohort
propensity score
propensity score decile
propranolol
prostate
protective effects
protective peptides
protein content
protein expression
protein kinase
protein kinase r-like er kinase
protein levels
proteins
proteome
proteomic remodeling
proteomics
protocol-driven poc testing
province of alberta
proximal circumflex artery
proximal lad
proximal left anterior descending
proximal left anterior descending artery
ps
psoriasis
psoriasis patients
psss
psychometric testing
psychosocial factors
psycinfo
public health
public reporting
pulmonar congestion
pulmonary
pulmonary arterial hypertension
pulmonary arterial hypertension medication
pulmonary arterial systolic pressure
pulmonary arterial vasculature
pulmonary arteries
pulmonary artery
pulmonary artery snared
pulmonary capillary wedge pressure
pulmonary congestion
pulmonary embolism
pulmonary hypertension
pulmonary hypertension patients
pulmonary vascular resistance
pulsatile afterload
pulsatile devices
pulse-wave velocity
pulseless ventricular fibrillation
pump exchanges
pump failure
pump malfunctions
pump thrombosis
pure epicatechin
pure hno donor to enhance myocardial function
pvf
pyridostigmine
pyridostigmine administration
q66p
qol
qrs
qrs complex
qrs duration
qrs morphology
qrs prolongation
qt intervals
qt variability
qtv
quality
quality improvement database
quality measures
quality of care programme
quality of life
quality of life assessment
quality-of-life score
quality-of-life scores
quantitative proteomics
québec randomized to rhythm
r-r interval oscillations
r. cluster analysis
ra
raas
rac2
race
rad
rad on cav1.2
rad q65p attenuates
rad q66p
rad q66p limits
rad variant
radial arterial tonometry
radial artery tonometry
radial strain
radioenzymatic-
raf-mek1/2-erk1/2 scaffold proteins
raf-mek1/2-erk1/2 signalling pathway
raised blood glucose levels
raloxifene
ramirez-sanchez
random-effects models
randomised-controlled trials
randomized trial
rapid right ventricular pacing
ras
ras axis
ras blockers
ras-
ras-blocker uptitration
rat left ventricular
rate control
rate-control
rate-control patients
rate-control strategies
rate-control treatment strategies
rats
rats enhanced pde2 expression
rcts
re-hospitalization
readmission
readmission metric
readmission metrics
readmission rate
readmission rates
readmission reduction program
readmissions
readmissions in heart failure
receiver operating characteristic curve
recent findings
reclassification
recommended therapies registry
recreational athletes
redo sternotomy
reducd
reducd lv contractility
reducd mortality
reduced ef
reduced ejection fraction
reducing mortality
ref
reference lists
refill compliance
refractory
refractory cardiogenic shock
refractory congestive heart failure
regional circumferential strain
regulate expression
regulation of feeding
regulator of growth
regulatory subunit
rehospitalization
relative wall thickness
relax-ahf
relaxation/viscoelastic
relevant health service provision
religious beliefs
rem2
remodeling
remote monitoring
renal
renal artery stenosis
renal atherosclerotic lesions
renal denervation
renal disease
renal dnx
renal dysfunction
renal function
renal impairment
renal optimization strategies evaluation
renal underperfusion
renin- angiotensin-aldosterone pathway
renin-angiotensin system
renin-angiotensin system blocker
renin-angiotensin-aldosterone
renin-angiotensin-aldosterone system
renin-angiotensin-aldosterone system inhibitors
reoperation
replicating resource use
repolarization instability
repolarization lability
residual confounding
resistance training
resistin
resistin levels
resource use
respiratory gas analysis
response after cardiac resynchronization therapy
resting hemodynamics
resting hr
resting tension
restrictive red blood cell transfusion strategy
resynchronization reverses remodeling
resynchronization-defibrillation
resynchronization-defibrillation for ambulatory heart failure trial
retention trial
retrospective cohort
retrospective cohort study
revascularization
reverse
reverse cardiac remodeling
reverse remodeling
reverse remodeling parameter
reversibility
reversible myocardial ischemia
rgk
rgk protein
rheumatic fever
rheumatoid arthritis
rhythm
rhythm control
rhythm control therapy
rhythm- and rate-control strategies
rhythm-control
ri
right atrial myxoma
right atrium mass
right coronary artery
right heart circulation
right heart circulatory failure
right heart failure
right heart filling pressures
right ventricular
right ventricular contractile reserve
right ventricular function
right ventricular support
right-sided cardiac catheterization
riiα
ring annuloplasty
risk
risk factors
risk for heart failure
risk for hospitalized heart failure
risk of death
risk of heart failure
risk of hospitalization
risk of long-term mortality
risk reduction
risk stratification
risk stratification models
risk-adjusted all-cause mortality
risk-adjusted mortality
riα
rm
rm strategies
rm trended to reduce all-cause mortality
rmsea
rna polymerase ii
robot-assisted gait therapy
robot-assisted training
rose
rr
rr intervals
rrna transcription
rs
rs synchrony
rtq-pcr
rv
rv dysfunction
rv failure
rv function
rv function evaluation
rv support
rvad
rvpo
rwt
s1pr1
s1pr1 agonist
s1pr1 downregulation
s1pr1)
s1pr1) reciprocal downregulation
s1pr1s
sa
sa in predicting adverse cv events
saf
saf cohort
safety end point
salt loading
sampling frame
sarcomere length relations
sarcomere shortening
sarcomeric microstructure
sarcoplasmic reticular
saxagliptin
saxagliptin users
scaffold protein
schfi
schfi v.6.2
sci
scientific literature
scn5a
scn5a electric remodeling
scn5a transcript
scn5a variants
score
sd
sd testosterone levels
sdqt
sdqt to sd
sdqt-to-sdrr ratio
sdrr
seattle heart failure model
segment-elevation mis
selective beta-blockers
self-care
self-care confidence
self-care confidence scale
self-care education
self-care maintenance
self-care maintenance scale
self-care management
self-care management scale
self-care of heart failure index
sensitivity
sepsis
septal defect
septal wall cs
septum
septum (systolic) thickness
sequential phosphorylation
ser23/24 troponin i phosphorylation
ser83 mutant riα proteins
ser83 phosphorylation
serial evaluation
serum albumin levels
serum creatinine level
serum cystatin c
serum factors
serum potassium level
serum resistin levels
severe ai
severe cad
severe end-stage hf
severe heart failure
severe hyperkalemia
severe hypertension
severe hyponatremia
severely reduced lvef
sex
sh
sham
sham levels
sham-dnx
sham-innervated
sham-inv
sham-operated
sham-operated animals
shift
shock therapy
short-form quality of life domains
short-term fractal scaling exponent
shotgun lc-ms
shunt implants
shuttle walk test
sickle cell disease
signal transduction cascade
signaling pathways
signalling cascades integrate
signalling pathways
signalling proteins
signalosome complex
simulations
sinus rhythm
sitagliptin
sitagliptin users
skeletal muscle
skeletal muscle abnormalities
skeletal muscle mass
skeletal muscle mass assessed
skeletal muscle mass correlated
skeletal muscle sarcomere structure
skinfold thickness
skm
skm biopsies
skm growth/differentiation
skm mitochondrial structure
slowed conduction
smad 2/3
small gtpase rac1 activity
small-molecule inhibitors
smoked
smoking
smoking cessation
snp rs10927887
social mandate
social support
sociale support
sodium
sodium-restricted dash diet
sodium-restricted dietary approaches to stop hypertension diet
soluble (s)st2
soluble guanylate cyclase
soluble st2 in ambulatory patients
southeastern minnesota residents
spearman correlations
speckle tracking echocardiography
sphingosine-1-phosphate
sphingosine-1-phosphate receptor
spironolactone
spironolactone dose
spontaneous ventricular tachycardia
spontaneous vt
sprague- dawley rats
sr
sr ca(2+)-pump
sr ca(2+)-pump function
ss20
sst2
sst2 concentrations
sst2 measurement
sst2 status
sst2 titrated to high-dose bb
sst2/high-dose bb
sst2/low-dose bb
st2
st2 levels
stabilized chronic heart failure
stable heart failure patients
stable hf
stable hfpef
stage i-iii breast cancer
standard cardiac rehabilitation
standard care
standard error of measurement
standard heart failure medicines
standing blood pressure
statitistical significance
ste
ste analysis
stent coated with a polytetrafluoroethylene tube
stenting
strain
strain rate
stress conditions
stress doppler echocardiography
stress echocardiography
stretch rate
stroke
stroke prevention trial
stroke volume
sts
sts hh
sts hm
student t test
study closure
study design
subcellular alterations
subclinical atherosclerosis
subpulmonary ventricle
sudden cardiac death
sudden cardiac deaths
sulfonylureas
surgery
surgical conditions
surgical method of transverse aortic constriction
surgical patients
surgical revascularization
surgical ring implantation
surgical tactics
survival
survival study
survival study in heart failure
sustainability
sv
svr
svr index
swedish national inpatient registry
swedish web-system for enhancement and development
swine
swine model
sympathetic
sympathetic activity
sympathetic control
sympathetic nervous systems
sympathetic outflow
sympathetic tone
sympathovagal balance
symptom limited maximal cpet
symptomatic adult fontan
symptomatic chronic advanced heart failure patients
syndrome
systematic review
systemic blood pressure
systemic hypertension
systemic vascular resistance
systemic/uv treatment
systems proteomics
systole
systolic
systolic blood pressure
systolic dysfunction
systolic elastance
systolic function
systolic heart failure
systolic heart failure treatment
systolic hf
systolic human heart failure
systolic left v entricular dysfunction
systolic mitral annulus velocity
systolic pressure
systolic ventricular function
szeto-schiller
t-score
t1 changes
t1 mapping
t1-mapping sequence
t1-mapping technique
t1-mapping values
t2d
t2d consumed erc
tac
tac surgery
tac-
tac-induced heart failure
tac-induced proteomic alterations
tachy-
tachycardia
tachycardia-induced heart failure
tachycardic response
tachypacing-induced hf
tapse
tapse vs pasp relationship
tapse-to-pasp ratio
tapse/pasp
target genes
taub
taxonomy
technical advisors
techniek
telehealth
tertiary referral centre
test-retest reliability
testosterone group
testosterone supplementation
testosterone therapy
tgf-β
tgf-β inhibition
tgf-β signaling
thalassaemia
therapeutic
therapeutic functions
therapeutic interruption
therapeutic left-to-right interatrial shunting
therapeutic strategy
therapeutic targets
therapeutic treatments
therapies
therapy
therapy refractory cardiogenic shock
thirty-day mortality
thoratec corp
thromboembolic events
thrombosis
thrombotic obstruction
tidal respiration
time domain heart rate variability
time to esrd
time-dependent covariates
timed up & go
tissue
tissue doppler imaging
tissuefaxs technology
titin hypophosphorylation
titin isoforms
titin modification
tm
tm interventions
tnf antagonist
tnf antagonists
tnfα
to death
tobacco
tolvaptan
total adiponectin
total cholesterol
total symptom domains
toxicity
traditional heart failure
trans
transcatheter
transcatheter aortic valve procedure
transcription
transcription factor dhand
transcription factor hand2 in heart failure
transcription factors
transcriptional pause release
transduction pathways
transforming growth factor beta-dependent yield
transforming growth factor-β
transfusion thresholds
transfusions
transgenic for the human retn gene
transient receptor potential cation channel m7
transitions of care program
transmitral e-wave/early diastolic mitral annular velocity
transmitral flow velocities
transoesophageal echocardiographic
transoesophageal echocardiography
transplant
transplant ineligible patients
transplant pool
transplant-ineligible patients
transplantation
transplantation eligibility status
transplantation to consultation
transplants
transseptal catheterisation
transthoracic echocardiography
transverse aortic constriction
trastuzumab
trastuzumab use
trastuzumab-related cardiotoxicity
trastuzumab-related chf
trastuzumab-treated patients
trastuzumb-related chf
treadmill exercise testing
treadmill testing
treating advanced hf
treatment
treatment for heart failure
treatments
trial-cardiac resynchronization therapy
trials
triangular resection
trichrome blue histologic
tricuspid annular plane systolic excursion
tricuspid valve
trigger hemoglobin threshold
troponin t
trpm7) channel mrna
tta/tetmena
tta/tgtetmena mice
tta/ttetmena mice
tug test
tumor necrosis factor
tunel
tunel assay
tunel-positive cells
tuscany
twist
two-vessel disease model
type 2 diabetes
type ii regulatory
uk
unclear etiology
uncontrolled hypertension
underlying heart disease
undiagnosed heart disease
undirectional left-to-right interatrial shunting
unfavorable outcome
unfit
unfit men
unfolded protein response
unilateral
unilateral renal dnx
uninephrectomy
unit costs
university of connecticut health center
university of connecticut heart failure center
university of michigan hf clinic
unloading
unplanned readmission
untranslated region
upr
upr effectors
urgent cardiac transplant
urgent readmission
uti
v end-diastolic volume
va cohort
va-rt cohort
vad
vad group
vad groups
vads
vagal
vagal tone
valve plasty
valvular
valvular disease
valvular regurgitation
vascular endothelial growth factor blockade
vascular endothelial growth factor protein
vascular stiffness
vasodilator effects
vasodilators
vasopeptidase inhibitors
vasopressin
vasopressin receptor antagonist
vasopressin receptor antagonist therapy
vd
vegetables
vegf
vegf inhibition counteracted
vegf signaling pathway
vegfr2
vehicle
velocity
velocity time integral
ven/ vco2 slope
ventilatory efficiency slope
ventricle
ventricle overload
ventricular
ventricular action potential duration
ventricular action potentials
ventricular assist device
ventricular assist device implantation
ventricular assist device support
ventricular assist devices
ventricular cardiomyocytes
ventricular contractile reserve
ventricular diastolic function
ventricular dilatation
ventricular dysfunction
ventricular ejection
ventricular ejection fraction
ventricular mass
ventricular power index
ventricular pressure overload
ventricular structure
ventricular systolic
ventricular systolic hf tissue samples
ventricular wall stress
ventricular-arterial coupling
ventricular-pulmonary arterial coupling
ventricularly paced
verficacy outcome
veterans
vh
video edge detection
virtual cohorts
vo
vo2
vo2max
voltage-gated ca(2+) channels
voltage-gated cardiac na+ channel α-subunit
volume overload
voordelen
vvd
vvd variations
wall stress
wasting
weak grip strength
weight
weight loss
western australian linked administrative health data
western blot
western blot analysis
western blots
white
whole grain intake
wilcoxon
wild type
wild-type littermates
wild-type rad
willebrand factor
wind association
wind cohort
women
womens health initiative
work load-corrected chronotropic response
world health organization website
wrf
writer
wstar-kyoto
wt
xanthine oxidase
xanthine oxidase inhibition
xo
xo inhibition
xo-mediated ros
xo-mediated ros effects
yorkshire swine
young woman
zebrafish
zsf1 groups
zsf1 rats
zung
zung self-rated depression scores
α-myosin heavy chain
β coefficient
β-adrenergic receptor agonist
β-adrenergic receptor blockade
β-adrenergic receptor blocker therapy
β-adrenoceptor blockade
β-ar
β-ar drive
β-ar responsiveness
β-ar stimulation
β-ar stimulation via catecholamine infusions
β-blockade
β-blocker
β-blocker dose
β-blocker metoprolol
β-blocker uptitration
β-blocker uptitrations
β-blocker-induced enhancement
β-blockers
β1-adrenergic receptor
β1ar
β1ars
β2-adrenergic receptor haplotype
β2-receptor
β2-receptor haplotype status
